Teladoc Health Inc
NYSE:TDOC
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
US |
Teladoc Health Inc
NYSE:TDOC
|
2.2B USD | 1 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 12 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.9 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 3.8 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 4.7 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 77.3 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 10.5 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 8 | ||
SE |
Sectra AB
STO:SECT B
|
42.7B SEK | 25.6 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.8 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.7 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.